Melatonin administration has been shown to significantly relieve hyperglycemia-induced alterations in cellular growth, apoptosis, and calcium influx by inhibiting the cascade of the PERK–eIF2α–ATF4–CHOP signaling axis [166]. The gene discussed is EIF2AK3; the disease is Hyperglycemia.